These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36557225)

  • 1. Metabolic Analysis of Nucleosides/Bases in the Urine and Serum of Patients with Alcohol-Associated Liver Disease.
    He L; Vatsalya V; Ma X; Klinge CM; Cave MC; Feng W; McClain CJ; Zhang X
    Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered urinary tryptophan metabolites in alcohol-associated liver disease.
    Xu R; Vatsalya V; He L; Ma X; Feng W; McClain CJ; Zhang X
    Alcohol Clin Exp Res (Hoboken); 2023 Sep; 47(9):1665-1676. PubMed ID: 37431708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics analysis of urine from patients with alcohol-associated liver disease reveals dysregulated caffeine metabolism.
    Xu R; He L; Vatsalya V; Ma X; Kim S; Mueller EG; Feng W; McClain CJ; Zhang X
    Am J Physiol Gastrointest Liver Physiol; 2023 Feb; 324(2):G142-G154. PubMed ID: 36513601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Profiling of Bile Acids in the Urine of Patients with Alcohol-Associated Liver Disease.
    He L; Vatsalya V; Ma X; Zhang J; Yin X; Kim S; Feng W; McClain CJ; Zhang X
    Hepatol Commun; 2021 May; 5(5):798-811. PubMed ID: 34027270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. t
    Nagayoshi Y; Nishiguchi K; Yamamura R; Chujo T; Oshiumi H; Nagata H; Kaneko H; Yamamoto K; Nakata H; Sakakida K; Kunisawa A; Adachi M; Kakizoe Y; Mizobe T; Kuratsu JI; Shimada S; Nakamori Y; Matsuoka M; Mukoyama M; Wei FY; Tomizawa K
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's in Metabolomics for Alcoholic Liver Disease?
    Suciu AM; Crisan DA; Procopet BD; Radu CI; Socaciu C; Tantau MV; Stefanescu HO; Grigorescu M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):51-58. PubMed ID: 29557415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.
    Harris PS; Michel CR; Yun Y; McGinnis CD; Assiri MA; Ahmadi AR; Sun Z; Roede JR; Burchill MA; Orlicky DJ; McCullough RL; Fritz KS
    Alcohol; 2022 Mar; 99():35-48. PubMed ID: 34923085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary acrolein metabolite levels in severe acute alcoholic hepatitis patients.
    Vatsalya V; Kong M; Gobejishvili L; Chen WY; Srivastava S; Barve S; McClain C; Joshi-Barve S
    Am J Physiol Gastrointest Liver Physiol; 2019 Jan; 316(1):G115-G122. PubMed ID: 30234998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunoglobulin A levels and alcohol-induced liver disease.
    Elias ED; Uhanova J; Minuk GY
    Can Liver J; 2020; 3(2):177-187. PubMed ID: 35991855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
    Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
    J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
    Way GW; Jackson KG; Muscu SR; Zhou H
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of urinary modified nucleosides and bases in rats with hepatomas and nephroblastomas.
    Clark I; MacKenzie JW; McCoy JR; Lin W
    Recent Results Cancer Res; 1983; 84():388-400. PubMed ID: 6302750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic Analysis Uncovers Energy Supply Disturbance as an Underlying Mechanism of the Development of Alcohol-Associated Liver Cirrhosis.
    Huang Y; Niu M; Jing J; Zhang ZT; Zhao X; Chen SS; Li SS; Shi Z; Huang A; Zou ZS; Yu YC; Xiao XH; Liangpunsakul S; Wang JB
    Hepatol Commun; 2021 Jun; 5(6):961-975. PubMed ID: 34141983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HMGB1 associates with liver disease and predicts readmission and mortality in patients with alcohol use disorder.
    Vannier AGL; Wardwell B; Fomin V; PeBenito A; Wolczynski N; Piaker S; Kedrin D; Chung RT; Schaefer E; Goodman R; Patel SJ; Luther J
    Alcohol; 2021 Sep; 95():37-43. PubMed ID: 34118353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linoleic Acid-Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol-Associated Liver Injury.
    Warner D; Vatsalya V; Zirnheld KH; Warner JB; Hardesty JE; Umhau JC; McClain CJ; Maddipati K; Kirpich IA
    Hepatol Commun; 2021 Jun; 5(6):947-960. PubMed ID: 34141982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
    Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
    Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
    Godoy AT; Eberlin MN; Simionato AVC
    Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and characterization of modified nucleosides in serum and urine of uremic patients using capillary liquid chromatography-frit-fast atom bombardment mass spectrometry.
    Takeda N; Yoshizumi H; Niwa T
    J Chromatogr B Biomed Sci Appl; 2000 Sep; 746(1):51-62. PubMed ID: 11048740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide.
    Shah ND; Ventura-Cots M; Abraldes JG; Alboraie M; Alfadhli A; Argemi J; Badia-Aranda E; Arús-Soler E; Barritt AS; Bessone F; Biryukova M; Carrilho FJ; Fernández MC; Dorta Guiridi Z; El Kassas M; Eng-Kiong T; Queiroz Farias A; George J; Gui W; Thurairajah PH; Hsiang JC; Husić-Selimovic A; Isakov V; Karoney M; Kim W; Kluwe J; Kochhar R; Dhaka N; Costa PM; Nabeshima Pharm MA; Ono SK; Reis D; Rodil A; Domech CR; Sáez-Royuela F; Scheurich C; Siow W; Sivac-Burina N; Dos Santos Traquino ES; Some F; Spreckic S; Tan S; Vorobioff J; Wandera A; Wu P; Yacoub M; Yang L; Yu Y; Zahiragic N; Zhang C; Cortez-Pinto H; Bataller R
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2320-2329.e12. PubMed ID: 30708110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of mass spectrometry-based metabolomics in identification of early noninvasive biomarkers of alcohol-induced liver disease using mouse model.
    Manna SK; Thompson MD; Gonzalez FJ
    Adv Exp Med Biol; 2015; 815():217-38. PubMed ID: 25427910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.